|
April 22, 2003
Pfizer must defend Rezulin lawsuit
- An appeal court reinstated a Rezulin lawsuit that was
dismissed in October 2001 in a lower court. The Rezulin lawsuit
alleged that Pfizer’s Warner-Lambert unit hid Rezulin
safety risks and continued to aggressively market Rezulin
despite the serious liver damages being reported. Rezulin
class action lawsuit status is currently being sought for
the damages suffered by Rezulin patients.
April 22, 2003
Rezulin fraud suit surfaces again - Rezulin Type
II diabetes drug was seen as progress in treatment options
when it was first introduced to the market in 1997. Forced
to make Rezulin labeling changes several times, Rezulin was
associated to liver failure and liver injury, leading up to
the March 2000 announcement of a Rezulin recall.
A fraud suit was brought against Rezulin drug makers by health
insurance companies that charged the Rezulin company continued
to claim it was safe despite reporting to the FDA that 31
Rezulin users had died in a 6-month period in 1998 and that
the Rezulin company continued to lie as more and more adverse
Rezulin reports were made.
A Southern District of New York judge had dismissed the Rezulin
case in October 2001. Now, the 2nd U.S. circuit Court of Appeals
has reversed the decision. The 2nd Circuit court disagreed
with the previous judge’s decision, a victory for Rezulin
users that had suffered serious and deadly Rezulin side effects.
Contact
us for more information on Rezulin side effects.
April 18, 2003
Hispanics informed of Rezulin lawsuit rights - A
high number of diabetic patients that used Rezulin prior to
the March 2000 recall have been filing Rezulin lawsuits for
the deadly and serious effects Rezulin caused. A June 2002
L.A. Times article was written stating legal documents exist
showing that Warner Lambert targeted Latinos while marketing
Rezulin, as well as paying doctors to have their diabetic
patients switch to using Rezulin. Now, Hispanic Rezulin patients
are becoming better informed of how the judicial system can
help recover damages for the serious Rezulin side effects
suffered.
April 3, 2003
Manhattan jury rules against Rezulin company - A
$2 million verdict favored a former Rezulin patient that suffered
Rezulin side effects, unanimously deciding there was “clear
and convincing” evidence showing Warner-Lambert misrepresented
or omitted Rezulin material information to physicians. At
the time of the Rezulin recall there had been around one hundred
people that either died or suffered from acute liver failure
that required liver transplant because of Rezulin diabetes
drug. Pfizer (which acquired Warner-Lambert in June 2000)
is appealing the Rezulin decision. The world’s largest
drug maker, Pfizer has had thousands of Rezulin lawsuits filed
against the company.
March 31, 2003
Rezulin class action lawsuit denied - In September
2002, U.S. judge denied a nationwide Rezulin class action
lawsuit and now a California appeals court denied a Rezulin
class action lawsuit for California residents as well. Although
this may appear a small victory for Pfizer, the world’s
largest drug company has had thousands of Rezulin lawsuits
filed against them, paying $11.5 million, $23.6 million, and
$2 million for Rezulin lawsuits the company lost, in addition
to paying $43 million to settle.
January 23, 2002
The most recent Rezulin lawsuit case has been decided,
awarding $24.9 million in punitive damages to the family of
a woman who died after taking Rezulin diabetes drug. Warner-Lambert,
Rezulin manufacturer, is planning on appealing the decision.
The Rezulin death was the result of liver damage. The jury
ruled that Warner-Lambert was guilty of negligence in developing
and marketing Rezulin.
The plaintiffs’ attorney in the Rezulin lawsuit stated
that the punitive damages awarded were less than they had
hoped for. The attorney for Warner-Lambert thinks that the
exorbitant fines awarded against the company are ineffective
because many of the executives that led the company during
Rezulin’s development and time on the market have since
left. Two million people took Rezulin before the March 2000
FDA Rezulin recall.
January 18, 2002
Pfizer Inc., who has since bought Warner-Lambert, said a California
judge denied class-action status to a Rezulin lawsuit that
claimed advertising for the diabetes drug misled consumers
about its health risks. The L.A. Superior Court Judge concluded
there were not enough common claims amongst more than 200,000
Rezulin users in California to let them pursue the false-advertising
Rezulin lawsuit as a class-action case.
Individual Rezulin lawsuits can still be pursued for injuries
endured by contacting
us to speak with an expert Rezulin lawyer. Rezulin
lawsuits account for the serious, life-threatening Rezulin
side effects have been directly linked to the use of the diabetes
drug. Warner-Lambert has been blamed in dozens of deaths from
liver failure and thousands of other liver damage cases from
1997-2000.
top
|
